LUCY vs. BPTS, AGRX, QNRX, ALBT, ARAV, MBIO, ISPC, CYCC, ZCMD, and ELOX
Should you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include Biophytis (BPTS), Agile Therapeutics (AGRX), Quoin Pharmaceuticals (QNRX), Avalon GloboCare (ALBT), Aravive (ARAV), Mustang Bio (MBIO), iSpecimen (ISPC), Cyclacel Pharmaceuticals (CYCC), Zhongchao (ZCMD), and Eloxx Pharmaceuticals (ELOX). These companies are all part of the "medical" sector.
Innovative Eyewear (NASDAQ:LUCY) and Biophytis (NASDAQ:BPTS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, dividends, risk, earnings, community ranking, valuation and media sentiment.
Innovative Eyewear presently has a consensus price target of $1.00, suggesting a potential upside of 424.66%. Biophytis has a consensus price target of $600.00, suggesting a potential upside of 7,199.27%. Given Biophytis' higher possible upside, analysts clearly believe Biophytis is more favorable than Innovative Eyewear.
Innovative Eyewear has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500. Comparatively, Biophytis has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.
Innovative Eyewear has higher revenue and earnings than Biophytis.
Biophytis received 4 more outperform votes than Innovative Eyewear when rated by MarketBeat users.
Biophytis has a net margin of 0.00% compared to Innovative Eyewear's net margin of -578.05%. Biophytis' return on equity of 0.00% beat Innovative Eyewear's return on equity.
In the previous week, Innovative Eyewear had 2 more articles in the media than Biophytis. MarketBeat recorded 2 mentions for Innovative Eyewear and 0 mentions for Biophytis. Innovative Eyewear's average media sentiment score of 0.45 beat Biophytis' score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the media.
1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 0.1% of Biophytis shares are owned by institutional investors. 11.1% of Innovative Eyewear shares are owned by insiders. Comparatively, 3.7% of Biophytis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Innovative Eyewear and Biophytis tied by winning 6 of the 12 factors compared between the two stocks.
Get Innovative Eyewear News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innovative Eyewear Competitors List
Related Companies and Tools
